SoftOx småprat

[XCR]

Hehe må jo bare le. Dette visste noen om på forhånd. 0,035 neste.

[erpe80]

Softox. Stay away
Mega emi pump

[rockpus]

Glemte du ikke en 0 der…?

[XCR]

Definitivt! Takk

[stAMy]

Uansett hva man klarer å skrape sammen av positiv optimisme i dette selskapet så vil du alltid bli skuffet. De vil aldri klare å levere og hvorfor i huleste vil man risikere pengene sine her når man kan tjene penger på 10/10 andre selskaper? Å putte penger i softox er det samme som å fyre i peisen med sedler.

[drdr]

Flytt pengene til LYTIX!
Fase3 klar produkt med kommersialiseringsavtale og milestone utbetaling!

[TekBot]

SoftOx Solutions AS: Private Placement resolved

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE’S REPUBLIC OF CHINA, SOUTH AFRICA, NEW ZEALAND, JAPAN OR THE UNITED STATES, OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL

Reference is made to Soft Softox Solutions AS’ (the “Company”) notice on 24 March 2025. Today, the Company has resolved to carry out the Private Placement and debt conversion and resolved to issue 289 163 052 new shares at a subscription price of NOK 0,035 per share (the “Share Issue”). The Share Issue has been resolved pursuant to the authorization granted by the extraordinary general meeting 31 July 2024. The Share Issue will generate approximately NOK 9 054 500 in gross proceeds before transaction costs.
…

Vis børsmeldingen

Norwegian and international investors participated in the Private Placement. The subscription price was set in accordance with market conditions (i.e 9,1% premium over the 7 days WWAP prior to March 21st 2025).

The Company will have a share capital of NOK 44 808 339,88 divided by 2 240 416 994 shares each with a nominal value of NOK 0,02 following registration of the Share Issue with the Norwegian Register of Business Enterprises.

Deviation from shareholders’ preferential rights

The board of directors has considered the Private Placement (and the Share Issue as a whole) in light of the equal treatment principles under the Norwegian Securities Trading Act and Oslo Børs’ Oslo Rule Book II – Membership and Trading Rules and Oslo Børs’ Circular no. 2/2014, and is of the opinion that the waiver of the preferential rights inherent in a private placement is considered necessary in the interest of time and successful completion in order to secure funding of the Company and reduce debt. Further, the Private Placement was launched after a market sounding process with several investors (including both new investors and existing shareholders) to reduce the transaction risk and the transaction secures a market-based subscription (i.e 9,1% premium over the 7 days WWAP prior to March 21st 2025). In addition, the Private Placement is limited and the shareholders will be given the opportunity to participate in a later financing round. Taking into consideration the time, costs, and expected terms of alternative methods of securing the necessary funding, as well as the contemplated later financing, the board of directors has concluded that the completion of the Private Placement, including the waiver of the preferential rights inherent to the Private Placement, is in the common interest of the shareholders of the Company. Further, the board has assessed whether a subsequent offering shall be carried out. As the Private Placement is limited, made without discount, and considering the cost inherent in a subsequent offering and contemplated later financing round, the board has concluded that a subsequent offering shall not be carried out.

This information is considered to be inside information pursuant to the EU Market Abuse Regulation and is subject to the disclosure requirements pursuant to section 5-12 the Norwegian Securities Trading Act.

For any questions please contact:

Ingrid Juven

CFO SoftOx Solutions AS

Mail: ir@soft-ox.com

Phone: Ingrid Juven: (+47) 918 76 165

Kilde

[TekBot]

SoftOx Solutions AS: Fourth Quarter Report 2024

Please find attached the Fourth Quarter Report 2024 for SoftOx Solutions AS.
…

Vis børsmeldingen

Kilde

[Ubruklig]

Nærstående har gjort store kjøp i uken som var. Spennende tider i selskapet

[Mrodseth]

Ellevilt, frister å ta på joggeskoene her også

[Ubruklig]

Har en solid følelse av at denne ser 12-16.øre
Mulig den må masseres litt en dag imorgen før det går brått videre

[XCR]

3 optimistiske kommentarer etter hverandre. Det begynner å bli en stund siden sist

[TekBot]

SoftOx Solutions AS: New Share Capital

Reference is made to the stock exchange release from SoftOx Solutions AS (the “Company”) on 25 March 2025 regarding the board resolution to increase the share capital by carrying out a private placement and a debt conversion converting outstanding claims to new shares in the Company.

The new share capital following the completion of the share capital increase has today been registered with the Norwegian Register of Business Enterprises.
…

Vis børsmeldingen

The new share capital of the Company is NOK 44 808 339,88 divided into 2 240 416 994 shares, each with a par value of NOK 0,02.

About SoftOx Solutions AS:
SoftOx Solutions AS (SoftOx) is a pharmaceutical company listed on Euronext Growth Oslo under ‘SOFTX’. SoftOx Solutions AS was founded in 2012 and is headquartered in Oslo. The SoftOx Solutions Group includes the holding company SoftOx Solutions AS, the Malmö subsidiary Water Innovation AB (WIAB), and the subsidiary SoftOx Defense Solutions AS. SoftOx is developing a highly effective antimicrobial solution for use in biofilm, viral, and antimicrobial-resistant infections. The patent-protected technology is based on extensive research and development in partnership with leading Nordic research institutes.

For more information on SoftOx, visit www.soft-ox.com

Kilde

[Ubruklig]

Leser på FA forum den er nå ukens aksje i investornytt. Duket for enda mer fart hehe…
Historisk går biotek aksjer i urolige tider

[polsmannen]

Snart markedsverdi 200mill…. Av en eller annen grunn…

[Aaleby]

Fullstendig shit show på Shareville. To the moon-retails som knapt har snøring på det fundamentale.

[helga]

Småsparerne som presser prisen opp, Almås snart solgt 54 mill aksjer. Folk er gale…

[polsmannen]

Flere selskap blandt de på topp som ikke har den aller beste likviditeten ref. proff. Som nå må gjøre noen «grep» før det er for

Pump and dump?

[Hotdog]

Driver Almåsen å dumper ut aksjer? #ikkeoverrasket

[Aaleby]

@Ubruklig

Dokumenter påstanden din.

Du skal ha for å gjøre ære på valg av navn her inne.

Harefrøken Invest har solgt seg ned fra 131 mill aksjer til 77 mill. Kvittet seg med nye 4 mill aksjer tirsdag denne uken.